Clinical Study


Posted Date: Oct 7, 2019

  • Investigator: Lawrence Goldstick
  • Specialties: Multiple Sclerosis, Neurology
  • Type of Study: Drug

A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis


Patients With Multiple Sclerosis Previously Treated With Ocrelizumab For At Least One Year, Or Patients Who Have Never Received Ocrelizumab


Primary Progressive Ms, Relapsing Remitting Ms

For More Information:

Melissa Gilchrist

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.